{"Q": 1, "answer": "no", "rationale": "The segment describes market movement, not the virus risk.", "method": "llm_batch", "batch_id": "batch_1_11568", "batch_size": 200, "batch_pos": 148, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "'climbed' describes stock market movement (background condition), not the threat's direct impact.", "method": "llm_batch", "batch_id": "batch_2_15264", "batch_size": 200, "batch_pos": 112, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Contains 'climbed 2.4%', but this refers to financial metrics, which are excluded from Q3.", "method": "llm_batch", "batch_id": "batch_3_15448", "batch_size": 200, "batch_pos": 24, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
